Oncogenic Viruses: Fundamentals of Oncoviruses provides an overview of the history of human oncoviruses, how to discover and define an oncovirus, how viruses cause cancer in general, their oncogenic mechanisms and epidemiology, and the cancer biology of oncoviruses. The book is organized into five main parts that include history and discovery of virus-tumor complications, taxonomy and classification of oncoviruses, oncoviruses around the world, including epidemiology statistics and current methods. Finally, the book looks at the molecular epidemiology of DNA and RNA viruses and their role in the pathogenesis of human cancers.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Part one: History, discovery and Taxonomy of viruses-tumor complications2. Part two: Taxonomy and classification of oncoviruses: Structural organization, Genetic organization, Oncoviruses Morphology in electronic microscopy
3. Part three: Oncoviruses around the world: epidemiology statistics; current methods and studies of oncoviruses.
4. Part four: DNA oncoviruses:
- A. Molecular epidemiology (Papillomaviridae Polyomaviridae (JC, BK, SIV), Adenoviridae, Herpesviridae, Hepadnaviridae)
- B. Cancer implications and associations:
(Human papilloma virus (HPV), Kaposi's sarcoma-associated herpes virus, Epstein-Barr virus (EBV or HHV-4), Merkel cell polyoma virus , Human cytomegalovirus (CMV or HHV-5)
5. Part five: RNA oncoviruses:
- A. molecular epidemiology (Retroviridae , Flaviviridae)
- B. Cancer implications and associations:
(Mammary mouse tumor viruses (MMTV), Human T-lymphotropic virus (HTLV1,), hepatitis C virus and hepatocarcinoma, retroviruses, Rous sarcoma virus (RSV)).
Authors
Moulay Mustapha Ennaji Professor, Virology and Oncology, University of Casablanca, Morocco; Director, Quality and Medical Biotechnologies Team, Laboratory of Virology Microbiology, Quality, Biotechnologies/Eco-Toxicology and Biodiversity; Faculty, Sciences and Techniques, Hassan II University Mohammedia of Casablanca, Morocco.Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.
